首页 > 最新文献

Forschende Komplementarmedizin最新文献

英文 中文
The Vegetarian Advantage: Its Potential for the Health of Our Planet, Our Livestock, and Our Neighbors! 素食的优势:它对我们的星球、我们的牲畜和我们的邻居的健康的潜力!
Pub Date : 2016-01-01 Epub Date: 2016-03-23 DOI: 10.1159/000444902
Gary E Fraser
Although vegetarianism has existed for thousands of years, the motivation originally came from philosophical and religious practices and traditions. Beginning about 200 years ago (particularly in the U.K., Germany and soon after the USA) there were prominent advocates for the positive effect of vegetarian diets on physical, and possibly mental health [1]. More recently there have been greater concerns about animal rights, in the last few decades the increasing focus on global warming, and the effects of modern society on the planet that have highlighted the predicted ecological benefits of vegetarian diets [2]. Consequently, motivations are now varied and often mixed.
{"title":"The Vegetarian Advantage: Its Potential for the Health of Our Planet, Our Livestock, and Our Neighbors!","authors":"Gary E Fraser","doi":"10.1159/000444902","DOIUrl":"https://doi.org/10.1159/000444902","url":null,"abstract":"Although vegetarianism has existed for thousands of years, the motivation originally came from philosophical and religious practices and traditions. Beginning about 200 years ago (particularly in the U.K., Germany and soon after the USA) there were prominent advocates for the positive effect of vegetarian diets on physical, and possibly mental health [1]. More recently there have been greater concerns about animal rights, in the last few decades the increasing focus on global warming, and the effects of modern society on the planet that have highlighted the predicted ecological benefits of vegetarian diets [2]. Consequently, motivations are now varied and often mixed.","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 2","pages":"66-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000444902","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34373708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis. 德国第一中医医院中药质量控制及并发症筛查项目回顾性分析。
Pub Date : 2016-01-01 Epub Date: 2016-05-30 DOI: 10.1159/000444983
Dieter Melchart, Stefan Hager, Jingzhang Dai, Wolfgang Weidenhammer

Background: The use of drugs derived from plants is a cornerstone of Traditional Chinese Medicine (TCM). Yet, too little is known about risk and safety of Chinese medicinal drugs (CMD). Therefore, the TCM hospital Bad Kötzting has developed a quality control and complication screening programme in order to ensure a safe administration of TCM drugs to their patients.

Methods: All Chinese medicinal drugs delivered to the hospital between September 1, 2012 and December 31, 2013 entered the quality control program and were screened for microbial contamination, aflatoxin, pesticides and heavy metals. A routinely applied complication screening programme monitored liver enzymes in all patients. Case causality assessment by CIOMS scale and identification of admitted herbs were conducted. Additionally, side effects of patients were identified by a routinely performed web-based documentation system.

Results: In 5 of 23 investigated samples (21.7%) the initial testing showed microbial contamination (2), pesticide (2) and heavy metals (1). The drugs were tested for authenticity and adulterations, respectively. All 994 patients (mean age 52.6 years; 72.6% female) admitted were available for analysis. 448 (45.1%) of all patients reported having perceived at least one side effect of treatment. They experienced mainly gastrointestinal symptoms (13.6%), neurovegetative symptoms (10.8 %), temporary deteriorations of pain (8.8%), diarrhoea (5.9%), nausea (1.6%) and vomiting (0.5%). Further, 6 patients with a more than 2-fold elevation (compared to maximum normal value or elevated admission values) of ALT were found in the systematic laboratory control with a non-conclusive causality assessment for TCM-drugs.

Conclusion: Approximate incidence rates and analysed drugs associated with liver damage revealed a low rate of liver injury. Patients should be informed of the gastrointestinal symptoms caused by and potential hepatotoxicity of TCM herbs.

背景:植物源性药物的使用是中医的基石。然而,人们对中药的风险和安全性知之甚少。因此,中医院Bad Kötzting制定了质量控制和并发症筛查方案,以确保患者安全服用中药。方法:2012年9月1日至2013年12月31日交付该院的所有中药材均进入质量控制程序,进行微生物污染、黄曲霉毒素、农药、重金属等检测。常规应用并发症筛查方案监测所有患者的肝酶。采用CIOMS量表对病例进行因果关系评价,并对入选药材进行鉴定。此外,通过基于网络的常规记录系统确定患者的副作用。结果:23份调查样品中5份(21.7%)初检出微生物污染(2份)、农药污染(2份)和重金属污染(1份),分别进行了真伪检验和掺假检验。994例患者(平均年龄52.6岁;72.6%为女性)。448例(45.1%)患者报告至少有一种治疗副作用。主要表现为胃肠道症状(13.6%)、神经植物症状(10.8%)、暂时性疼痛恶化(8.8%)、腹泻(5.9%)、恶心(1.6%)和呕吐(0.5%)。此外,在系统实验室对照中发现6例患者ALT升高超过2倍(与最大正常值或入院值相比),对中药进行了非结论性因果关系评估。结论:肝损伤发生率及相关药物分析显示肝损伤发生率低。患者应了解中药引起的胃肠道症状和潜在的肝毒性。
{"title":"Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.","authors":"Dieter Melchart,&nbsp;Stefan Hager,&nbsp;Jingzhang Dai,&nbsp;Wolfgang Weidenhammer","doi":"10.1159/000444983","DOIUrl":"https://doi.org/10.1159/000444983","url":null,"abstract":"<p><strong>Background: </strong>The use of drugs derived from plants is a cornerstone of Traditional Chinese Medicine (TCM). Yet, too little is known about risk and safety of Chinese medicinal drugs (CMD). Therefore, the TCM hospital Bad Kötzting has developed a quality control and complication screening programme in order to ensure a safe administration of TCM drugs to their patients.</p><p><strong>Methods: </strong>All Chinese medicinal drugs delivered to the hospital between September 1, 2012 and December 31, 2013 entered the quality control program and were screened for microbial contamination, aflatoxin, pesticides and heavy metals. A routinely applied complication screening programme monitored liver enzymes in all patients. Case causality assessment by CIOMS scale and identification of admitted herbs were conducted. Additionally, side effects of patients were identified by a routinely performed web-based documentation system.</p><p><strong>Results: </strong>In 5 of 23 investigated samples (21.7%) the initial testing showed microbial contamination (2), pesticide (2) and heavy metals (1). The drugs were tested for authenticity and adulterations, respectively. All 994 patients (mean age 52.6 years; 72.6% female) admitted were available for analysis. 448 (45.1%) of all patients reported having perceived at least one side effect of treatment. They experienced mainly gastrointestinal symptoms (13.6%), neurovegetative symptoms (10.8 %), temporary deteriorations of pain (8.8%), diarrhoea (5.9%), nausea (1.6%) and vomiting (0.5%). Further, 6 patients with a more than 2-fold elevation (compared to maximum normal value or elevated admission values) of ALT were found in the systematic laboratory control with a non-conclusive causality assessment for TCM-drugs.</p><p><strong>Conclusion: </strong>Approximate incidence rates and analysed drugs associated with liver damage revealed a low rate of liver injury. Patients should be informed of the gastrointestinal symptoms caused by and potential hepatotoxicity of TCM herbs.</p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 Suppl 2 ","pages":"21-8"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000444983","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34447001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
[Erratum]. (错误)。
Pub Date : 2016-01-01 Epub Date: 2016-06-30 DOI: 10.1159/000446685
{"title":"[Erratum].","authors":"","doi":"10.1159/000446685","DOIUrl":"https://doi.org/10.1159/000446685","url":null,"abstract":"","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 3","pages":"192"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000446685","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34658819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inter-Rater Reliability of Neck Reflex Points in Women with Chronic Neck Pain. 慢性颈部疼痛妇女颈部反射点的评分间信度。
Pub Date : 2016-01-01 Epub Date: 2016-06-23 DOI: 10.1159/000447506
Stefan Weinschenk, Richard Göllner, Markus W Hollmann, Lorenz Hotz, Susanne Picardi, Katharina Hubbert, Thomas Strowitzki, Thomas Meuser

Background: Neck reflex points (NRP) are tender soft tissue areas of the cervical region that display reflectory changes in response to chronic inflammations of correlated regions in the visceral cranium. Six bilateral areas, NRP C0, C1, C2, C3, C4 and C7, are detectable by palpating the lateral neck. We investigated the inter-rater reliability of NRP to assess their potential clinical relevance.

Methods: 32 consecutive patients with chronic neck pain were examined for NRP tenderness by an experienced physician and an inexperienced medical student in a blinded design. A detailed description of the palpation technique is included in this section. Absence of pain was defined as pain index (PI) = 0, slight tenderness = 1, and marked pain = 2. Findings were evaluated either by pair-wise Cohen's kappa (ĸ) or by percentage of agreement (PA).

Results: Examiners identified 40% and 41% of positive NRP, respectively (PI > 0, physician: 155, student: 157) with a slight preference for the left side (1.2:1). The number of patients identified with >6 positive NRP by the examiners was similar (13 vs. 12 patients). ĸ values ranged from 0.52 to 0.95. The overall kappa was ĸ = 0.80 for the left and ĸ = 0.74 for the right side. PA varied from 78.1% to 96.9% with strongest agreement at NRP C0, NRP C2, and NRP C7. Inter-rater agreement was independent of patients' age, gender, body mass index and examiner's experience.

Conclusion: The high reproducibility suggests the clinical relevance of NRP in women.

背景:颈部反射点(NRP)是颈部柔软的软组织区域,对内脏颅骨相关区域的慢性炎症反应表现出反射性变化。6个双侧区域,NRP C0, C1, C2, C3, C4和C7,可通过触诊外侧颈部检测到。我们调查了NRP的评分者间信度,以评估其潜在的临床相关性。方法:采用盲法设计,由一名经验丰富的医生和一名经验不足的医学生对32例慢性颈部疼痛患者进行NRP压痛检查。本节将详细介绍触诊技术。无疼痛定义为疼痛指数(PI) = 0,轻微压痛= 1,明显疼痛= 2。研究结果通过配对科恩kappa ()或同意百分比(PA)进行评估。结果:检查人员分别发现40%和41%的NRP阳性(PI > 0,医生:155,学生:157),并轻微倾向于左侧(1.2:1)。检查人员确定的>6个阳性NRP的患者数量相似(13例对12例)。取值范围为0.52 ~ 0.95。左侧总体kappa为 = 0.80,右侧总体kappa为 = 0.74。PA变化范围为78.1% ~ 96.9%,其中NRP C0、NRP C2和NRP C7的一致性最强。评分者之间的一致性与患者的年龄、性别、体重指数和审查员的经验无关。结论:高重复性提示NRP在女性中的临床应用价值。
{"title":"Inter-Rater Reliability of Neck Reflex Points in Women with Chronic Neck Pain.","authors":"Stefan Weinschenk,&nbsp;Richard Göllner,&nbsp;Markus W Hollmann,&nbsp;Lorenz Hotz,&nbsp;Susanne Picardi,&nbsp;Katharina Hubbert,&nbsp;Thomas Strowitzki,&nbsp;Thomas Meuser","doi":"10.1159/000447506","DOIUrl":"https://doi.org/10.1159/000447506","url":null,"abstract":"<p><strong>Background: </strong>Neck reflex points (NRP) are tender soft tissue areas of the cervical region that display reflectory changes in response to chronic inflammations of correlated regions in the visceral cranium. Six bilateral areas, NRP C0, C1, C2, C3, C4 and C7, are detectable by palpating the lateral neck. We investigated the inter-rater reliability of NRP to assess their potential clinical relevance.</p><p><strong>Methods: </strong>32 consecutive patients with chronic neck pain were examined for NRP tenderness by an experienced physician and an inexperienced medical student in a blinded design. A detailed description of the palpation technique is included in this section. Absence of pain was defined as pain index (PI) = 0, slight tenderness = 1, and marked pain = 2. Findings were evaluated either by pair-wise Cohen's kappa (ĸ) or by percentage of agreement (PA).</p><p><strong>Results: </strong>Examiners identified 40% and 41% of positive NRP, respectively (PI > 0, physician: 155, student: 157) with a slight preference for the left side (1.2:1). The number of patients identified with >6 positive NRP by the examiners was similar (13 vs. 12 patients). ĸ values ranged from 0.52 to 0.95. The overall kappa was ĸ = 0.80 for the left and ĸ = 0.74 for the right side. PA varied from 78.1% to 96.9% with strongest agreement at NRP C0, NRP C2, and NRP C7. Inter-rater agreement was independent of patients' age, gender, body mass index and examiner's experience.</p><p><strong>Conclusion: </strong>The high reproducibility suggests the clinical relevance of NRP in women.</p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 4","pages":"223-9"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000447506","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34729891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
[Beweggründe von Krebspatienten für und gegen die Inanspruchnahme der Misteltherapie]. [癌症患者使用手语治疗的动机]。
Pub Date : 2016-01-01 Epub Date: 2016-08-24 DOI: 10.1159/000448745
Kathrin M Gschwendtner, Christine Holmberg, Joachim Weis

Einleitung: Die Misteltherapie ist im deutschsprachigen Raum ein häufig angewandtes komplementärmedizinisches Verfahren (KM) in der Onkologie. Diese Studie hatte das Ziel, die Beweggründe für oder gegen eine Inanspruchnahme der Misteltherapie zu untersuchen und Themenfeldern zuzuordnen. Patienten und Methoden: Es wurden qualitative leitfadengestützte Interviews mit Krebspatienten geführt. Der Interviewleitfaden fragte nach der Inanspruchnahme von KM, der Motivation zur Inanspruchnahme, Informationsverhalten und -bedürfnissen zu KM sowie nach der Krebserkrankung. Um die Beweggründe für die Inanspruchnahme oder Nichtinanspruchnahme der Misteltherapie zu verstehen, wurden die Interviews inhaltsanalytisch ausgewertet. Ergebnisse: Insgesamt wurden Interviews mit 88 Krebspatienten geführt, davon nutzen 18 (20,5%) die Misteltherapie. Die Beweggründe für oder gegen eine Inanspruchnahme der Misteltherapie ließen sich den 2 Themenfeldern «Wahrgenommene Indikation» und «Abwägungen bei der Entscheidungsfindung» zuordnen. Diskussion und Schlussfolgerungen: Mit der Misteltherapie wird sowohl ein Einfluss auf das Tumorwachstum als auch eine supportive Wirkung assoziiert. Anwender sehen die Misteltherapie als sicheres Verfahren; Nichtnutzer befürchten eher Neben- oder Wechselwirkungen. Die Empfehlung von Fachpersonal spielt eine wichtige Rolle bei der Inanspruchnahme. Zum Teil waren die Nichtnutzer interessiert an der Anwendung der Misteltherapie, befanden sich jedoch noch im Klärungsprozess.

引言:德语国家在肿瘤学是经常应用补充疗法(KM)的。本研究的目的是调查冬眠治疗使用的动机,并把主题分类。对病人与研究方法是有目的地对恶性肿瘤进行探询。采访指南询问了使用KM / h的情况,也询问了使用KM / h的信息行为和需求,还有癌症。为了了解使用或不接受mi出国治疗的动机,我们进行了内容分析访问。研究结果:共接受了88名癌症病人的采访,其中18人使用了槲寄生治疗(20.5%)。动机赞成还是反对诉诸威胁下的Misteltherapie 2日Themenfeldern«的Indikation»和«Abwägungen决策中».来源讨论和结论:槲寄生治疗同时对肿瘤生长有积极的影响,对体内的汤效也有补充作用。用户将化妆治疗视为一种安全方式;非用户更害怕相互作用或相互作用。专业人士的推荐在调配方面起着重要的作用。一些非用户对槲寄生的使用感兴趣,但他们还在确认过程中。
{"title":"[Beweggründe von Krebspatienten für und gegen die Inanspruchnahme der Misteltherapie].","authors":"Kathrin M Gschwendtner,&nbsp;Christine Holmberg,&nbsp;Joachim Weis","doi":"10.1159/000448745","DOIUrl":"https://doi.org/10.1159/000448745","url":null,"abstract":"<p><p>Einleitung: Die Misteltherapie ist im deutschsprachigen Raum ein häufig angewandtes komplementärmedizinisches Verfahren (KM) in der Onkologie. Diese Studie hatte das Ziel, die Beweggründe für oder gegen eine Inanspruchnahme der Misteltherapie zu untersuchen und Themenfeldern zuzuordnen. Patienten und Methoden: Es wurden qualitative leitfadengestützte Interviews mit Krebspatienten geführt. Der Interviewleitfaden fragte nach der Inanspruchnahme von KM, der Motivation zur Inanspruchnahme, Informationsverhalten und -bedürfnissen zu KM sowie nach der Krebserkrankung. Um die Beweggründe für die Inanspruchnahme oder Nichtinanspruchnahme der Misteltherapie zu verstehen, wurden die Interviews inhaltsanalytisch ausgewertet. Ergebnisse: Insgesamt wurden Interviews mit 88 Krebspatienten geführt, davon nutzen 18 (20,5%) die Misteltherapie. Die Beweggründe für oder gegen eine Inanspruchnahme der Misteltherapie ließen sich den 2 Themenfeldern «Wahrgenommene Indikation» und «Abwägungen bei der Entscheidungsfindung» zuordnen. Diskussion und Schlussfolgerungen: Mit der Misteltherapie wird sowohl ein Einfluss auf das Tumorwachstum als auch eine supportive Wirkung assoziiert. Anwender sehen die Misteltherapie als sicheres Verfahren; Nichtnutzer befürchten eher Neben- oder Wechselwirkungen. Die Empfehlung von Fachpersonal spielt eine wichtige Rolle bei der Inanspruchnahme. Zum Teil waren die Nichtnutzer interessiert an der Anwendung der Misteltherapie, befanden sich jedoch noch im Klärungsprozess. </p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 4","pages":"215-22"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000448745","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34372955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Impact of Soy Foods on the Development of Breast Cancer and the Prognosis of Breast Cancer Patients. 大豆食品对乳腺癌发展及乳腺癌患者预后的影响。
Pub Date : 2016-01-01 Epub Date: 2016-04-12 DOI: 10.1159/000444735
Mark Messina

The relationship between soy food intake and breast cancer has been rigorously investigated for more than 25 years. The identification of isoflavones as possible chemopreventive agents helped fuel this line of investigation. These diphenolic compounds, which are found in uniquely-rich amounts in soy beans, possess both estrogen-dependent and -independent properties that potentially inhibit the development of breast cancer. Observational studies show that among Asian women higher soy consumption is associated with an approximate 30% reduction in risk of developing breast cancer. However, evidence suggests that for soy to reduce breast cancer risk consumption must occur early in life, that is during childhood and/or adolescence. Despite the interest in the role of soy in reducing breast cancer risk concerns have arisen that soy foods, because they contain isoflavones, may increase the likelihood of high-risk women developing breast cancer and worsen the prognosis of breast cancer patients. However, extensive clinical and epidemiologic data show these concerns to be unfounded. Clinical trials consistently show that isoflavone intake does not adversely affect markers of breast cancer risk, including mammographic density and cell proliferation. Furthermore, prospective epidemiologic studies involving over 11,000 women from the USA and China show that postdiagnosis soy intake statistically significantly reduces recurrence and improves survival.

大豆食品摄入和乳腺癌之间的关系已经被严格调查了25年以上。异黄酮作为可能的化学预防剂的鉴定有助于推动这一调查路线。这些二酚类化合物在大豆中含量丰富,具有雌激素依赖性和非依赖性,可能抑制乳腺癌的发展。观察性研究表明,在亚洲女性中,较高的大豆摄入量与患乳腺癌的风险降低约30%有关。然而,有证据表明,要想降低患乳腺癌的风险,食用大豆必须在生命的早期,也就是童年和/或青春期。尽管人们对大豆在降低乳腺癌风险方面的作用很感兴趣,但也有人担心大豆食品,因为它们含有异黄酮,可能会增加高风险女性患乳腺癌的可能性,并使乳腺癌患者的预后恶化。然而,广泛的临床和流行病学数据表明,这些担忧是没有根据的。临床试验一致表明,摄入异黄酮不会对乳腺癌风险指标产生不利影响,包括乳房x线摄影密度和细胞增殖。此外,来自美国和中国的11000多名女性的前瞻性流行病学研究表明,诊断后摄入大豆可显著减少复发并提高生存率。
{"title":"Impact of Soy Foods on the Development of Breast Cancer and the Prognosis of Breast Cancer Patients.","authors":"Mark Messina","doi":"10.1159/000444735","DOIUrl":"https://doi.org/10.1159/000444735","url":null,"abstract":"<p><p>The relationship between soy food intake and breast cancer has been rigorously investigated for more than 25 years. The identification of isoflavones as possible chemopreventive agents helped fuel this line of investigation. These diphenolic compounds, which are found in uniquely-rich amounts in soy beans, possess both estrogen-dependent and -independent properties that potentially inhibit the development of breast cancer. Observational studies show that among Asian women higher soy consumption is associated with an approximate 30% reduction in risk of developing breast cancer. However, evidence suggests that for soy to reduce breast cancer risk consumption must occur early in life, that is during childhood and/or adolescence. Despite the interest in the role of soy in reducing breast cancer risk concerns have arisen that soy foods, because they contain isoflavones, may increase the likelihood of high-risk women developing breast cancer and worsen the prognosis of breast cancer patients. However, extensive clinical and epidemiologic data show these concerns to be unfounded. Clinical trials consistently show that isoflavone intake does not adversely affect markers of breast cancer risk, including mammographic density and cell proliferation. Furthermore, prospective epidemiologic studies involving over 11,000 women from the USA and China show that postdiagnosis soy intake statistically significantly reduces recurrence and improves survival. </p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 2","pages":"75-80"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000444735","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34468221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 50
[Abstract Service]. (抽象服务)。
Pub Date : 2016-01-01 Epub Date: 2016-06-30 DOI: 10.1159/000447571
{"title":"[Abstract Service].","authors":"","doi":"10.1159/000447571","DOIUrl":"https://doi.org/10.1159/000447571","url":null,"abstract":"","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 3","pages":"193-5"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000447571","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34658820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New Analytical Monographs on TCM Herbal Drugs for Quality Proof. 中药质量检验新分析专论。
Pub Date : 2016-01-01 Epub Date: 2016-05-30 DOI: 10.1159/000444730
Hildebert Wagner, Rudolf Bauer, Dieter Melchart

Regardless of specific national drug regulations there is an international consensus that all TCM drugs must meet stipulated high quality standards focusing on authentication, identification and chemical composition. In addition, safety of all TCM drugs prescribed by physicians has to be guaranteed. During the 25 years history of the TCM hospital Bad Kötzting, 171 TCM drugs underwent an analytical quality proof including thin layer as well as high pressure liquid chromatography. As from now mass spectroscopy will also be available as analytical tool. The findings are compiled and already published in three volumes of analytical monographs. One more volume will be published shortly, and a fifth volume is in preparation. The main issues of the analytical procedure in TCM drugs like authenticity, botanical nomenclature, variability of plant species and parts as well as processing are pointed out and possible ways to overcome them are sketched.

不管国家有什么具体的药品法规,国际上有一个共识,即所有中药必须符合规定的高质量标准,重点是认证、鉴定和化学成分。此外,医生开的所有中药的安全性都必须得到保证。Bad中医院Kötzting在25年的历史中,对171种中药进行了薄层和高压液相色谱分析质量证明。从现在开始,质谱也可以作为分析工具。这些发现已汇编并出版了三卷分析专著。不久将再出版一卷,第五卷正在编写中。指出了中药分析过程中存在的主要问题,如真伪、植物命名、植物种类和部位的变异以及炮制等,并提出了解决这些问题的可能途径。
{"title":"New Analytical Monographs on TCM Herbal Drugs for Quality Proof.","authors":"Hildebert Wagner,&nbsp;Rudolf Bauer,&nbsp;Dieter Melchart","doi":"10.1159/000444730","DOIUrl":"https://doi.org/10.1159/000444730","url":null,"abstract":"<p><p>Regardless of specific national drug regulations there is an international consensus that all TCM drugs must meet stipulated high quality standards focusing on authentication, identification and chemical composition. In addition, safety of all TCM drugs prescribed by physicians has to be guaranteed. During the 25 years history of the TCM hospital Bad Kötzting, 171 TCM drugs underwent an analytical quality proof including thin layer as well as high pressure liquid chromatography. As from now mass spectroscopy will also be available as analytical tool. The findings are compiled and already published in three volumes of analytical monographs. One more volume will be published shortly, and a fifth volume is in preparation. The main issues of the analytical procedure in TCM drugs like authenticity, botanical nomenclature, variability of plant species and parts as well as processing are pointed out and possible ways to overcome them are sketched. </p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"23 Suppl 2 ","pages":"16-20"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000444730","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34553379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Condurango 30C Induces Epigenetic Modification of Lung Cancer-specific Tumour Suppressor Genes via Demethylation. Condurango 30C通过去甲基化诱导肺癌特异性肿瘤抑制基因的表观遗传修饰。
Pub Date : 2015-01-01 Epub Date: 2015-06-18 DOI: 10.1159/000433485
Anisur R Khuda-Bukhsh, Sourav Sikdar

Background: DNA hypermethylation induces cancer progression involving CpG island of DNA and causes inactivation of tumour suppressor genes. In this study, DNA hypermethylation status of lung cancer and ability of ultra-highly diluted Condurango 30C to modulate DNA methylation were ascertained by analysis of lung cancer-specific tumour suppressor genes in respect to placebo.

Materials and methods: DNA methylation status, if any, was determined by PCR-SSCP analyses in lung cancer-specific tumour suppressor genes (p15, p16 and p53) using H460-NSCLC cell and BaP-induced lung cancer of rats. The ability of Condurango 30C to modulate DNA methylation, if any, was verified against placebo control in blinded manner.

Results: Condurango 30C-treated DNA showed significant decrease in band intensity of p15 and p53 genes especially in methylated condition in vitro, at IC50 dose (2.43µl/100µl). SSCP analysis of p15 and p53 genes in Condurango 30C-treated DNA also suggests that Condurango 30C can decrease methylation, in vitro. Inhibition of p15 hypermethylation was observed in post-cancer treatment of rats with Condurango 30C. SSCP results gave a better indication of differences in band position of p15 and p53 in Condurango 30C-treated lung samples.

Conclusion: Condurango 30C could trigger epigenetic modification in lung cancer via modulation of DNA hypermethylation.

背景:DNA超甲基化诱导肿瘤进展,涉及DNA CpG岛并导致肿瘤抑制基因失活。在本研究中,通过分析肺癌特异性肿瘤抑制基因,确定肺癌DNA高甲基化状态和超高稀释Condurango 30C调节DNA甲基化的能力。材料和方法:使用H460-NSCLC细胞和bap诱导的大鼠肺癌,通过PCR-SSCP分析肺癌特异性肿瘤抑制基因(p15、p16和p53)的DNA甲基化状态(如果有的话)。Condurango 30C调节DNA甲基化的能力,如果有的话,与安慰剂对照进行了盲法验证。结果:Condurango 30c处理的DNA在IC50剂量(2.43µl/100µl)下,p15和p53基因的条带强度显著降低,尤其是在体外甲基化状态下。Condurango 30C处理的DNA中p15和p53基因的SSCP分析也表明Condurango 30C可以降低体外甲基化。观察到Condurango 30C对癌症后大鼠p15超甲基化的抑制作用。SSCP结果能更好地指示Condurango 30c处理肺样品中p15和p53条带位置的差异。结论:Condurango 30C可能通过调控DNA超甲基化引发肺癌的表观遗传修饰。
{"title":"Condurango 30C Induces Epigenetic Modification of Lung Cancer-specific Tumour Suppressor Genes via Demethylation.","authors":"Anisur R Khuda-Bukhsh,&nbsp;Sourav Sikdar","doi":"10.1159/000433485","DOIUrl":"https://doi.org/10.1159/000433485","url":null,"abstract":"<p><strong>Background: </strong>DNA hypermethylation induces cancer progression involving CpG island of DNA and causes inactivation of tumour suppressor genes. In this study, DNA hypermethylation status of lung cancer and ability of ultra-highly diluted Condurango 30C to modulate DNA methylation were ascertained by analysis of lung cancer-specific tumour suppressor genes in respect to placebo.</p><p><strong>Materials and methods: </strong>DNA methylation status, if any, was determined by PCR-SSCP analyses in lung cancer-specific tumour suppressor genes (p15, p16 and p53) using H460-NSCLC cell and BaP-induced lung cancer of rats. The ability of Condurango 30C to modulate DNA methylation, if any, was verified against placebo control in blinded manner.</p><p><strong>Results: </strong>Condurango 30C-treated DNA showed significant decrease in band intensity of p15 and p53 genes especially in methylated condition in vitro, at IC50 dose (2.43µl/100µl). SSCP analysis of p15 and p53 genes in Condurango 30C-treated DNA also suggests that Condurango 30C can decrease methylation, in vitro. Inhibition of p15 hypermethylation was observed in post-cancer treatment of rats with Condurango 30C. SSCP results gave a better indication of differences in band position of p15 and p53 in Condurango 30C-treated lung samples.</p><p><strong>Conclusion: </strong>Condurango 30C could trigger epigenetic modification in lung cancer via modulation of DNA hypermethylation.</p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"22 3","pages":"172-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000433485","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33401085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine. 小心空隙!非专业人士和医学人士对使用替代疗法和传统医学相关风险的认识。
Pub Date : 2015-01-01 Epub Date: 2015-02-19 DOI: 10.1159/000376555
Anita Salamonsen

Background: Studies on the widespread use of complementary and alternative medicine (CAM) demonstrate that CAM users base their treatment decisions on both subjective, experience-based knowledge and medical knowledge. The aim of this study was to explore lay and medical risk perceptions associated with CAM and conventional medicine.

Patients and methods: In this explorative qualitative study, we conducted in-depth interviews with 25 Norwegian CAM users with cancer or multiple sclerosis and 12 doctors.

Results: The interviews revealed fundamental differences in risk perceptions influencing treatment decisions and risk communication in a clinical setting. While CAM users considered conventional medicine as potentially risky and related this to experiences of severe adverse effects, CAM was perceived as natural and safe. Doctors' risk perceptions were quite the contrary, mainly because of lack of scientific evidence for CAM as a safe and beneficial treatment option.

Conclusion: For the safety of CAM users, such divergent risk perceptions may have far-reaching consequences. CAM users should be taken seriously with their self-perception as decision-makers considering their approaches to experiences, knowledge, and science. An awareness of differing lay and medical risk perceptions associated with CAM and conventional medicine in research, doctor-patient communication, and education of patients and doctors is thus important to optimize patient safety in complex health care systems.

背景:关于补充和替代医学(CAM)广泛使用的研究表明,CAM使用者的治疗决策既基于主观的、基于经验的知识,也基于医学知识。本研究的目的是探讨与CAM和传统医学相关的外行和医疗风险认知。患者和方法:在这项探索性质的研究中,我们对25名挪威癌症或多发性硬化症CAM使用者和12名医生进行了深入访谈。结果:访谈揭示了在临床环境中影响治疗决策和风险沟通的风险认知的根本差异。虽然辅助医学使用者认为传统医学有潜在风险,并将其与严重不良反应的经历联系起来,但辅助医学被认为是自然和安全的。医生的风险认知恰恰相反,这主要是因为缺乏科学证据证明CAM是一种安全有益的治疗选择。结论:对于CAM使用者的安全,这种不同的风险认知可能会产生深远的影响。作为决策者,CAM用户应该认真对待他们的自我认知,考虑他们获取经验、知识和科学的方法。因此,在研究、医患沟通以及对患者和医生的教育方面,认识到与CAM和传统医学相关的不同的非专业和医疗风险观念,对于优化复杂卫生保健系统中的患者安全非常重要。
{"title":"Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.","authors":"Anita Salamonsen","doi":"10.1159/000376555","DOIUrl":"https://doi.org/10.1159/000376555","url":null,"abstract":"<p><strong>Background: </strong>Studies on the widespread use of complementary and alternative medicine (CAM) demonstrate that CAM users base their treatment decisions on both subjective, experience-based knowledge and medical knowledge. The aim of this study was to explore lay and medical risk perceptions associated with CAM and conventional medicine.</p><p><strong>Patients and methods: </strong>In this explorative qualitative study, we conducted in-depth interviews with 25 Norwegian CAM users with cancer or multiple sclerosis and 12 doctors.</p><p><strong>Results: </strong>The interviews revealed fundamental differences in risk perceptions influencing treatment decisions and risk communication in a clinical setting. While CAM users considered conventional medicine as potentially risky and related this to experiences of severe adverse effects, CAM was perceived as natural and safe. Doctors' risk perceptions were quite the contrary, mainly because of lack of scientific evidence for CAM as a safe and beneficial treatment option.</p><p><strong>Conclusion: </strong>For the safety of CAM users, such divergent risk perceptions may have far-reaching consequences. CAM users should be taken seriously with their self-perception as decision-makers considering their approaches to experiences, knowledge, and science. An awareness of differing lay and medical risk perceptions associated with CAM and conventional medicine in research, doctor-patient communication, and education of patients and doctors is thus important to optimize patient safety in complex health care systems.</p>","PeriodicalId":51049,"journal":{"name":"Forschende Komplementarmedizin","volume":"22 1","pages":"24-9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000376555","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33173998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
期刊
Forschende Komplementarmedizin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1